Cargando…
Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid
BACKGROUND: To date, patients with pre-existing autoimmune conditions have been excluded from immunotherapy trials out of concern for severe autoimmune exacerbations. CASE PRESENTATION: We describe the first case of a patient with metastatic cKIT mutated acral melanoma, brain metastasis, and pre-exi...
Autores principales: | Beck, Kristen M., Dong, Joanna, Geskin, Larisa J., Beltrani, Vincent P., Phelps, Richard G., Carvajal, Richard D., Schwartz, Gary, Saenger, Yvonne M., Gartrell, Robyn D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835882/ https://www.ncbi.nlm.nih.gov/pubmed/27096097 http://dx.doi.org/10.1186/s40425-016-0123-3 |
Ejemplares similares
-
Pembrolizumab-induced bullous pemphigoid
por: Sun, Christina W., et al.
Publicado: (2019) -
Bullous Pemphigoid in a Patient Treated with Pembrolizumab
por: Hara, Kanako, et al.
Publicado: (2019) -
Covid‐19 dermatoses: Acral vesicular pattern evolving into bullous pemphigoid
por: Goon, P.K.C., et al.
Publicado: (2020) -
Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid
por: Wang, Jianglin, et al.
Publicado: (2023) -
Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports
por: Thomsen, Kenneth, et al.
Publicado: (2018)